MedCity News February 22, 2024
Now more than ever, enhancing primary care practices to include CGM capabilities is a crucial goal requiring the support and involvement of the broader healthcare community.
Medicare’s April 2023 decision to increase coverage for continuous glucose monitoring (CGM) was a major development for diabetes management. Now, with over a million new eligible beneficiaries and many more to follow this year, CGM usage is expected to grow at a record pace – and primary healthcare providers will play a major role.
Before Medicare’s coverage increase, domestic spending on CGMs was approximately $8 billion. However, that amount is expected to double in the next two years. In addition to the promise it holds for improved diabetes management, the expansion provides opportunities for...